Reimagining Early Access: Building a Multi-Stakeholder Funding Model to Close the Access Gap
- Addressing growing delays in patient access to innovative medicines and where current systems are failing
- Designing a funding model that enables access beyond donation-based programmes through shared ecosystem contribution
- Navigating legal, supply, and operational considerations to ensure access remains compliant and controlled
- Engaging stakeholders across pharma, patients, payers, and philanthropy to enable scalable access